title: Clinical safety and efficacy of celiprolol.
abstract: The management of essential hypertension requires therapeutic selections that are not only effective in reducing diastolic blood pressure but are also tailored to the individual patient, with minimal effect on patient demographics, concurrent illnesses, and cardiovascular risk factors. Celiprolol hydrochloride is a new highly cardioselective vasodilating beta-adrenoceptor antagonist that has been proven effective and safe for the treatment of essential hypertension. It is comparable to other therapies in blood pressure control while demonstrating an excellent safety profile, favorable hemodynamic activity, and minimal effects on other cardiovascular risk factors. Celiprolol may offer the physician a unique therapeutic alternative.
authors.affiliation: Department of Clinical Research and Regulatory Affairs, Rhône-Poulenc Rorer Central Research, Horsham, PA 19002.
authors.forename: K D
authors.initials: KD
authors.lastname: Lamon
mesh_terms: D001794:Blood Pressure / Q000187:drug effects*; D017272:Celiprolol; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D011412:Propanolamines / Q000009:adverse effects / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D011412:Propanolamines; D014665:Vasodilator Agents; D017272:Celiprolol